Stock Abbreviation: Hanyu Pharmaceutical
Stock Code: 300199
Shenzhen Hanyu Pharmaceutical Co., Ltd.
2026 Restricted Stock Incentive Plan
(Draft)
July 2026
Statement
The Company and all directors guarantee that this incentive plan and its summary contain no false records, misleading statements, or material omissions, and assume individual and joint legal liability for their authenticity, accuracy, and completeness.
Special Notice
-
This incentive plan is formulated in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Administrative Measures for Equity Incentives of Listed Companies, the Rules Governing the Listing of Stocks on the ChiNext Market of the Shenzhen Stock Exchange, the Guidelines for Self-Regulation of Listed Companies on the ChiNext Market No. 1—Business Handling, the Articles of Association of Shenzhen Hanyu Pharmaceutical Co., Ltd., and other relevant regulations.
-
The incentive instrument for this plan is restricted stock (Type II restricted stock). The source of the shares is A-share common shares repurchased by Shenzhen Hanyu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") from the secondary market and/or issued via private placement.
-
This incentive plan intends to grant no more than 19.50 million restricted shares to the incentive targets, accounting for approximately 2.21% of the Company's total share capital at the time of the announcement of this draft. Of this, 17.35 million shares will be granted for the first time, accounting for approximately 1.96% of the total share capital and approximately 88.97% of the total equity proposed to be granted; 2.15 million shares are reserved, accounting for approximately 0.24% of the total share capital and approximately 11.03% of the total equity proposed to be granted.
As of the date of the announcement of this draft, the total number of underlying shares involved in all of the Company's equity incentive plans within the validity period does not exceed 20.00% of the Company's total share capital at the time of the announcement. The cumulative number of company shares granted to any single incentive target under all equity incentive plans within the validity period does not exceed 1.00% of the Company's total share capital at the time of the announcement.
From the date of the announcement of this draft until the completion of the vesting of the restricted shares granted to the incentive targets, if the Company undergoes capital reserve conversion, stock dividend distribution, stock split, allotment, or share consolidation, the number of restricted shares granted shall be adjusted accordingly.
- The number of incentive targets for the initial grant under this plan shall not exceed 111 people, including directors, senior management, company (including subsidiary) management personnel, and other core business (technical) personnel. It does not include independent directors, shareholders or actual controllers who individually or collectively hold more than 5% of the listed company's shares, or their spouses, parents, or children. This complies with the provisions of Article 8.4.2 of the Rules Governing the Listing of Stocks on the ChiNext Market of the Shenzhen Stock Exchange, and none of the following circumstances that disqualify an individual as an incentive target exist:
(1) Being identified as an inappropriate candidate by a stock exchange within the last 12 months;
(2) Being identified as an inappropriate candidate by the China Securities Regulatory Commission (CSRC) and its dispatched offices within the last 12 months;
(3) Being subject to administrative penalties or market entry bans by the CSRC and its dispatched offices within the last 12 months due to major violations of laws and regulations;
(4) Having circumstances specified in the Company Law that prohibit one from serving as a director or senior manager of a company;
(5) Being prohibited from participating in equity incentives of listed companies by laws and regulations;
(6) Other circumstances recognized by the CSRC.